Yuslina Mat Yusoff

Yuslina Mat Yusoff

Auto-generated profile, based on publicly available information

Yuslina Mat Yusoff

Hematology Unit, Cancer Research Centre (CaRC), Institute for Medical Research (IMR), National Institutes of Health (NIH)

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2026 in Hemoglobin
Verified
Journal Article
Open access
EEEzalia Esa
Ezalia Esa
SHSyahzuwan Hassan
Syahzuwan Hassan
YYYuslina Mat Yusoff
Yuslina Mat Yusoff
NYNorafiza Yasin
Norafiza Yasin
FHFaidatul Syazlin Abdul Hamid
Faidatul Syazlin Abdul Hamid
ABAzlinda Abu Bakar
Azlinda Abu Bakar
α-Globin triplication increases α/non-α-chain imbalance and may lead to a symptomatic β-thalassemia carrier. We describe a novel, de novo large segmental duplication, ααα102 in a patient who is a β-thalassemia IVS 1-1 (G > T) (HBB:c0.92 + 1G > T) carrier and presented with thalassemia intermedia. The duplication spans from intron II, position 203 of the N-methylpurine DNA glycosylase (MPG) gene, to the downstream region of the Hemoglobin Subunit Theta 1 (HBQ1) gene (GRCh38.p14) (HGVS NC_000016.10:g.79903_181947dup). The heterozygous β-thalassemia IVS 1-1 (G > T) was inherited from the father, while the mother was negative for thalassemia. α-MLPA analysis revealed multiple polymorphisms in the father; however, neither parent had the duplication. We concluded that the segmental duplication occurred de novo. In pre-marital screening programs, α-triplications and duplicated α-globin loci should be investigated when one partner has β-thalassemia or a β-thalassemia carrier.

2 March 2026 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
NDNor Soleha Mohd Dali
Nor Soleha Mohd Dali
NANursaedah Abdullah Aziz
Nursaedah Abdullah Aziz
MZMuhamad Farid Zulkifle
Muhamad Farid Zulkifle
DZDurar Aqilah Zamri
Durar Aqilah Zamri
NKNor Rizan Kamaluddin
Nor Rizan Kamaluddin
YYYuslina Mat Yusoff
Yuslina Mat Yusoff
Introduction: B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) is a prevalent pediatric hematologic malignancy characterized by diverse chromosomal aberrations that significantly influence its prognosis. This study aimed to comprehensively characterize the genomic landscape of BCP‐ALL in 55 Malaysian patients with BCP‐ALL. Methods: Single‐nucleotide polymorphism (SNP) 6.0 microarray and multiplex ligation‐dependent probe amplification were utilized to characterize and validate copy‐number abnormalities involving key oncogenes, respectively. Results: The SNP 6.0 microarray identified 191 copy‐number abnormalities in 55 patients, including common subtypes such as hyperdiploidy ( n = 14/191, 7.3%), hypodiploidy ( n = 2/191, 1.1%), and various copy‐number abnormalities such as interstitial (23.0%), terminal (17.2%), focal (37.1%), and intragenic (18.0%). Notably, intrachromosomal amplification of chromosome 21 (iAMP21) was not observed, suggesting its rarity in this cohort. Comparison with conventional cytogenetic techniques, including Trypsin‐Leishman's banding karyotyping, fluorescent in situ hybridization (FISH), and reverse transcription‐polymerase chain reaction (RT‐PCR), revealed superior resolution of the SNP 6.0 microarray in detecting submicroscopic copy‐number abnormalities. Furthermore, MLPA confirmed abnormalities in several oncogenes, including CDKN2A/B , EBF1 , ERG , ETV6 , IKZF1 , JAK2 , and PAX5 . Conclusion: This study demonstrates the utility of combined SNP 6.0 microarray and MLPA in providing a comprehensive and refined understanding of the genetic landscape of BCP‐ALL in the Malaysian population. This understanding may facilitate risk stratification and the development of personalized treatment strategies.

1 March 2026
Verified
Journal Article
Open access
NDNor Soleha Mohd Dali
Nor Soleha Mohd Dali
NANursaedah Abdullah Aziz
Nursaedah Abdullah Aziz
MZMuhamad Farid Zulkifle
Muhamad Farid Zulkifle
DZDurar Aqilah Zamri
Durar Aqilah Zamri
NKNor Rizan Kamaluddin
Nor Rizan Kamaluddin
YYYuslina Mat Yusoff
Yuslina Mat Yusoff
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a prevalent pediatric hematologic malignancy characterized by diverse chromosomal aberrations that significantly influence its prognosis. This study aimed to comprehensively characterize the genomic landscape of BCP-ALL in 55 Malaysian patients with BCP-ALL. Single-nucleotide polymorphism (SNP) 6.0 microarray and multiplex ligation-dependent probe amplification were utilized to characterize and validate copy-number abnormalities involving key oncogenes, respectively. The SNP 6.0 microarray identified 191 copy-number abnormalities in 55 patients, including common subtypes such as hyperdiploidy (n = 14/191, 7.3%), hypodiploidy (n = 2/191, 1.1%), and various copy-number abnormalities such as interstitial (23.0%), terminal (17.2%), focal (37.1%), and intragenic (18.0%). Notably, intrachromosomal amplification of chromosome 21 (iAMP21) was not observed, suggesting its rarity in this cohort. Comparison with conventional cytogenetic techniques, including Trypsin-Leishman's banding karyotyping, fluorescent in situ hybridization (FISH), and reverse transcription-polymerase chain reaction (RT-PCR), revealed superior resolution of the SNP 6.0 microarray in detecting submicroscopic copy-number abnormalities. Furthermore, MLPA confirmed abnormalities in several oncogenes, including CDKN2A/B, EBF1, ERG, ETV6, IKZF1, JAK2, and PAX5. This study demonstrates the utility of combined SNP 6.0 microarray and MLPA in providing a comprehensive and refined understanding of the genetic landscape of BCP-ALL in the Malaysian population. This understanding may facilitate risk stratification and the development of personalized treatment strategies.